PROGRAMMA preliminare rev 5 ELITA MONOTHEMATIC CONFERENCE ... · Georges-Philippe Pageaux Montpellier, France Massimo Puoti Milan, Italy Didier Samuel Paris, France Mario Strazzabosco

Liver transplantation inHCV positive recipients:

facing a new Era

ELITA/ESOTMonothematic Conference

MILANATAHOTEL

EXECUTIVE

6th MARCH2015

SCIENTIFIC COMMITTEELuca Saverio BelliChristophe Duvoux

ELITA BOARD MEMBERSPaolo Muiesan ChairmanChristophe Duvoux Vice-ChairmanWojciech Polak SecretaryGabriela Berlakovich TreasurerRenè Adam Custodian of ELTRLuca Saverio Belli William Bennet Martin OliveriusAndreas Pascher Jacques Pirenne Roberto Troisi

FACULTYRenè Adam Paris, FranceAlessio Aghemo Milan, ItalyKosh Agarwal London, United KingdonLuca Saverio Belli Milan, ItalyMarina Berenguer Valencia, SpainThomas Berg Lipsia, GermanyPatrizia Burra Padua, ItalyMassimo Colombo Milan, ItalyAudrey Coilly Paris, FranceLuciano De Carlis Milan, ItalyChristophe Duvoux Paris, FranceStefano Fagiuoli Bergamo, ItalyXavier Forns Barcelona, SpainSaye Khoo Liverpool, United KingdonLorenzo Mantovani Milan, ItalyVincezo Mazzaferro Milan, ItalyGeorges-Philippe Pageaux Montpellier, FranceMassimo Puoti Milan, ItalyDidier Samuel Paris, FranceMario Strazzabosco Milan, Italy

MEETING VENUEAtahotel Executive

Viale Don Luigi Sturzo, 45 20154 Milan - Italy

Tel. +39 02 62942802

MEETING SECRETARIAT AND CME PROVIDER

MI&T SrlViale Carducci, 50

40125 Bologna - Italy Tel. +39 051 220427 Fax +39 051 0822077

[email protected] www.mitcongressi.it

REGISTRATION FEEELITA/ESOT Member € 100,00 with renewal ELITA membership 2015

NonMember € 350,00to register please access www.mitcongressi.it and click on

“ELITA Monothematic Conference”

Hotel Booking: in order to book a room at Atahotel Executive you can call the Central Booking Office at n. +39 06 69646964

asking for the “Elita” agreement

UNRESTRICTED GRANT BY

Platinum

Gold

Silver

..........................................................................................................................................

..........................................................................................................................................

08.25 Welcome and introductionELITA Chair and L.S. Belli

1st SESSION - The facts and the perspectivesChairs: M. Berenguer (Valencia, Spain) and M. Colombo (Milan, Italy)

08.30-08.45Epidemiology of HCV infection in Europe and future prospects A. Aghemo (Milan, Italy)

08.45-09.00Liver transplantation in HCV+ve recipients: data from the ELTR R. Adam (Paris, France)

09.00-09.15The limits of previous antiviral therapies both pre and post Liver transplantation A. Coilly (Paris, France)

09.15-09.45The new weapons and their combination in early 2015 and a 5 year outlook T. Berg (Lipsia, Germany)

09.45-10.15The new weapons in the perspective of Liver transplantation: focus on drug metabolism in case of liver or kidney dysfunction, drug interactions with immunosuppressants and toxicityS. Khoo (Liverpool, UK)

10.15-10.30Questions and Answers

10.30-10-50Coffee break

2rd SESSION - The new weapons in the specific setting of Liver transplantationChairs: X. Forns (Barcelona, Spain) and D. Samuel (Paris, France)

10.50-11.10 IFN free regimens in de-compensated cirrhotics: virological aspects L.S. Belli (Milan, Italy)

11.10-11.30IFN free regimens in de-compensated cirrhotics: clinical aspects D. Samuel (Paris, France)

11.30-11.50IFN free regimens in compensated cirrhotics with HCC C. Duvoux (Paris, France)

11.50-12.30 Round table 1 - Management of the patient on the waiting listCoordinator: L.S. BelliDiscussants: D. Samuel, X. Forns, M. Berenguer, C. Duvoux, S. Fagiuoli

12.30-13.30 Lunch

13.30-14.00IFN free regimens for post transplant HCV disease recurrence: non cirrhotics, cirrhoticsX. Forns (Barcelona, Spain)

14.00-14.15Special population: Fibrosing Cholestatic Hepatitis G.P. Pageaux (Montpellier, France)

14.15-14.30 Special population: HIV-HCV pre and post transplantM. Puoti (Milan, Italy)

14.30-14.45Extrahepatic manifestations of Hep C recurrence: impact of DAA on renal function and diabetes. What can we expect?M. Berenguer (Valencia, Spain)

14.45-15.20 Round table 2 - Treatment of post transplant HCV disease recurrenceCoordinator: C. DuvouxDiscussants: D. Samuel, X. Forns, M. Berenguer, M. Puoti, L.S. Belli

3rd SESSION - Social burden and CostsChairs: M. Strazzabosco (Milan, Italy) and L. De Carlis (Milan, Italy)

15.20-15.40Cost effectiveness and sustainability in the context of Liver transplantationL.Mantovani (Milan, Italy)

15.40-15.55Expected epidemiologic changes in the liver transplant lists in EuropeS. Fagiuoli (Bergamo, Italy)

15.55-16.10HCC and DAA: the point of view of the surgeonV. Mazzaferro (Milan, Italy)

16.10-16.30Questions and Answers

16.30-17.20 Round table 3 - Availability and use of new DAAs though EuropeCoordinators: K. Agarwal (London, UK) and M. Strazzabosco (Milan, Italy)Discussants: Expert from different European Countries

17.20-17.30 Skype connection with EASL EU Policy CouncellorP. Burra (Padua, Italy)

17.30-17.40Summing up L.S. Belli, C. Duvoux

17.40 Closing remarks ELITA Chair